arrow
M

Marco Zecca

irccs fondazione san matteo
H指数:71
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world utilization of thrombopoietin receptor agonists in the italian hematopoietic stem cell transplantation setting: a comprehensive national survey by the Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO)

意大利造血干细胞移植背景下促血小板生成素受体激动剂的实际应用:Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) 开展的全面全国性调查

2026-09-180
PRE
Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia?

成人EBMT风险评分对于儿童急性白血病的造血干细胞移植是否有效和适用?

2026-07-200
OA
Management of Iron Overload in Infants and Toddlers With Diamond–Blackfan Anemia Syndrome: A French–Italian Study

婴儿和幼儿型戴蒙德-布莱克芬贫血综合征铁过载的管理:一项法意研究

2026-05-110
OA
Second Allogeneic Hematopoietic Cell Transplantation After Graft Failure Is an Effective Curative Option in Children With Hemoglobinopathies

第二次异基因造血细胞移植在造血移植物失败后是儿童血红蛋白病的一种有效治愈选择。

2026-04-070
OAAI
Encouraging Outcomes in Pediatric Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Results From the Italian HLH Registry

儿童恶性相关噬血淋巴组织细胞增生症的积极结果:意大利HLH登记研究的成果

2026-03-120
OAAI
Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT)

Defibrotide用于儿童高危患者窦状阻塞综合征/静脉闭塞病(SOS/VOD)的预防:欧洲血液与骨髓移植学会(EBMT)的共识指南

2026-01-130
OAAI
DNA Methylation Episignature as a Novel Diagnostic Tool for Diamond-Blackfan Anemia Syndrome

DNA甲基化表观签名作为Diamond-Blackfan贫血综合征的新型诊断工具

2025-11-170
OAAI
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP

比较BuCy与BuCyMel作为异基因HSCT预处理方案在首次完全缓解期婴儿急性髓系白血病中的疗效:一项来自EBMT PDWP的多中心研究

2025-10-280
PRE
A phase I/II study of brentuximab vedotin + AVD in paediatric patients with advanced Hodgkin lymphoma

一项brentuximab vedotin + AVD的I/II期研究,用于治疗晚期霍奇金淋巴瘤的儿科患者

2025-10-140
OAAI
Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study

评估外周血DNA甲基化特征作为阿扎胞苷治疗儿童髓系单核细胞白血病期间药效学和预测性生物标志物的应用:EWOG-MESRAT研究的结果

2025-07-310
OAAI
Early HHV-6 reactivation increases the risk of graft rejection after haploidentical hematopoietic cell transplantation

早期人疱疹病毒6型(HHV-6)再激活增加了半相合造血细胞移植后移植物排斥的风险。

2025-06-280
PRE
Control of BKPyV-DNAemia by a Tailored Viro-Immunologic Approach Does Not Lead to BKPyV-Nephropathy Progression and Development of Donor-Specific Antibodies in Pediatric Kidney Transplantation

通过量身定制的病毒免疫学方法控制BKPyV-dna血症不会导致小儿肾移植中BKPyV-肾病的进展和供体特异性抗体的发展

2024-12-300
OAAI
Report of the Italian Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome in the Target Therapy Era
2024-12-230
OAAI